Cargando…
Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
Background: Nephrotoxicity is a notable adverse effect in cisplatin treated patients characterized by tubular injury and/or increased serum creatinine (SCr) with incidence varying from 20 to 70%. Pharmacogenomics has been shown to identify strongly predictive genetic markers to help determine which...
Autores principales: | Zazuli, Zulfan, Vijverberg, Susanne, Slob, Elise, Liu, Geoffrey, Carleton, Bruce, Veltman, Joris, Baas, Paul, Masereeuw, Rosalinde, Maitland-van der Zee, Anke-Hilse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171472/ https://www.ncbi.nlm.nih.gov/pubmed/30319427 http://dx.doi.org/10.3389/fphar.2018.01111 |
Ejemplares similares
-
Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients
por: Zazuli, Zulfan, et al.
Publicado: (2020) -
The Impact of Genetic Polymorphisms in Organic Cation Transporters on Renal Drug Disposition
por: Zazuli, Zulfan, et al.
Publicado: (2020) -
Outcome Definition Influences the Relationship between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients
por: Zazuli, Zulfan, et al.
Publicado: (2019) -
Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study
por: Zazuli, Zulfan, et al.
Publicado: (2021) -
Dibenzazepine Attenuates Against Cisplatin-Induced Nephrotoxicity in Rats: Involvement of NOTCH Pathway
por: Abd El-Rhman, Rana H., et al.
Publicado: (2020)